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ABSTRACT
This study used NMR-based metabolomics to compare the metabolic profile of different ana-
tomical compartments of cereal grains i.e. bran and endosperm in order to gain further insights 
into their possible role in the beneficial health effects of whole grain products (WG). Polar water-
soluble metabolites in 64 bran and endosperm, samples from rye and wheat were observed using 
600 MHz NMR. Bran samples had higher contents of 12 metabolites than endosperm samples. A 
comparative approach revealed higher contents of azelaic acid and sebacic acid in bran than in 
endosperm. In a pilot study, the consumption of WG rye bread (485 g) caused NMR signals in 24h 
urine corresponding to azelaic acid. The relatively high abundance, anatomical specificity, pat-
tern of metabolism, urinary excretion in human, antibacterial, and anticancer activities suggest 
further studying of azelaic acid when exposure to WG or beneficial effects of WG are investigated.
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INTRODUCTION
Epidemiological studies have consistent-
ly shown that intake of whole grain (WG) can 
protect against the development of chronic dis-
eases (SLAVIN et al. 2001), e.g. type 2 diabetes 
(T2D) (DE MUNTER et al. 2007, MURTAUGH et 
al. 2003), cardiovascular disease (CVD) (FLINT 
et al. 2009; JACOBS et al. 2007; MELLEN et al. 
2008), and certain cancers (CHAN et al. 2007, 
HAAS et al. 2009; LARSSON et al. 2005; SCHATZ-
KIN et al. 2008). The American Association of 
Cereal Chemists provided the following scien-
tific and botanical definition of WG in 1999: 
“whole grain shall consist of the intact, ground, 
cracked or flaked caryopsis, whose principal 
anatomical component-the starchy endosperm, 
germ and bran-are present in the same rela-
tive proportion as they exist in the intact cary-
opsis” (International 1999). Whole grains are a 
rich source of fiber and bioactive compounds, 
including tocopherols, B vitamins, minerals, 
phenolic acids, and phytoestrogens (FARDET, 
2010). It is generally recognized that the syn-
ergistic action of compounds mainly present in 
the bran and germ fractions of cereals accounts 
for the protective effects of WG products (FAR-
DET, 2010; LIU, 2007). Recently, the composi-
tion and the diversity of bioactive compounds 
in different anatomical components of cereal 
grains have been systematically investigated in 
a large number of different species and varie-
ties within the HEALTHGRAIN project (NYSTROM 
et al. 2008; SHEWRY et al. 2010; WARD et al. 
2008). However, that project screened the cereal 
samples for bioactive compounds already doc-
umented in cereals using a targeted approach, 
and made no comparison of the untagged pro-
file of the metabolites in different compartments 
of cereal grains.
Metabolomics is an untargeted approach in 
which the profile of metabolites in a biospeci-
men is measured using high-throughput analyt-
ical methods, e.g. NMR and mass spectrometry 
(LENZ and WILSON, 2007; NICHOLSON and WIL-
SON 2003). We have used this approach previ-
ously to examine the complex physiological/bio-
chemical effects of WG rye products in humans 
(MOAZZAMI et al. 2012; MOAZZAMI et al. 2014; 
MOAZZAMI et al. 2011). The aim of the present 
study was to search for the discriminative me-
tabolites in the two major anatomical compart-
ments in cereal grain, endosperm and bran, us-
ing an untargeted NMR-based metabolomics ap-
proach and with the emphasis on wheat and rye 
to gain further insights into their possible role 
in the beneficial health effects of whole grain 
products. NMR analysis can potentially pro-
vide characteristic structural data, which can 
be used for elucidation and eventual identifica-
tion of unknown compounds found to discrimi-
nate between the metabolic profiles of bran and 
endosperm in cereals. 
MATERIALS AND METHODS
Serial sample collection and extraction
A total of 64 cereal samples, comprising 18 
wheat endosperm, 24 wheat bran, 8 rye en-
dosperm, and 14 rye bran were obtained from 
the HEALTHGRAIN (WARD et al. 2008) project or 
from a local market. The endosperm and bran 
samples originated from HEALTHGRAIN projects 
were from the same grain sample material and 
therefore were matched (Wheat samples n = 
18; and rye samples n = 8). The HEALTHGRAIN 
project rye varieties (and populations) included 
potugaise-3, potugaise-6, Haute Loire, Gran-
drieu, Nikita, Rekrut, Dankowskie-Zlote, and 
Lovaszpatonai-1. The details about rye va-
rieties are given in NYSTROM et al. (2008). 
The HEALTHGRAIN project wheat varieties in-
cluded Disponent, Herzog, Tommi, Campari, 
Tremie, San Pastore, Gloria, Spartanka, Ava-
lon, Claire, Malacca, Maris Huntsman, Rial-
to, Riband, Obriy, CF99105, Chinese-Spring, 
and Cadenza. The details about wheat varie-
ties are given by SHEWRY et al. (2010). All rye 
and wheat varieties were grown in the field at 
Martonvasar, Hungary, in 2005. Full details 
of the site including soil type, mineral compo-
sition, and weather condition has been given 
by SHEWRY et al. (2010).
All samples were milled, and 0.5 g milled ma-
terial was extracted in 5 mL Milli-Q water for 18 
h. The samples were then centrifuged (5 min-
1500 g), and 2 mL supernatant was extracted, 
mixed with 8 mL ethanol and centrifuged (15 
min-1,500 g) in order to precipitate the soluble 
viscose polymers. A 5 mL portion of the ethanol 
supernatant was dried using an evacuated cen-
trifuge (Savant, SVC 100H, Savant Instrument 
INC, NJ) and dissolved in phosphate buffer (280 
µL, 0.25 mol/L, pH 7.0), D2O (40 µL), and sodi-
um-3-(trimethylsilyl)-2,2,3,3-tetradeuteriopropi-
onate solution (TSP, 30 µL, 23.2 mmol/L) (Cam-
bridge Isotope Laboratories, Andover, MA). The 
mixture was then used for 1H NMR analysis. 
An internal standard was added to the mixture 
in order to ensure semi-quantitative measure-
ments of metabolites captured by 1H NMR. For 
2D NMR analysis the mixture was freeze-dried 
and dissolved in D2O before analysis.
Human experiment and the preparation of 
urine sample for NMR analysis
In a pilot study, a male subject (age 35; BMI 
= 23.4) consumed refined wheat bread 485 g 
for 6 days (breakfast 2 portions, lunch 1 por-
tion, dinner 1 portion). On day six, 24-hour 
urine was collected. On day seven, he substi-
tuted the 485 g refined wheat bread with 485 
g of whole grain rye bread and the urine was 
collected for 24 hours. During the seven days 
of experiment, any other cereal products were 
avoided. The choice of consuming refined wheat 
bread vs whole grain rye bread was made to 
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replicate the condition of previous human in-
terventions in which refined wheat bread was 
used as the control diet (MOAZZAMI et al. 2011; 
MOAZZAMI et al. 2012; BONDIA-PONS et al. 
2013). The refined wheat bread was prepared 
from commercial refined wheat flour and whole 
grain rye bread was prepared from commercial 
whole grain rye flour. The whole trial was re-
peated twice, in two different times. This study 
complied with the Helsinki Declaration, as re-
vised in 1983. The urine samples were kept in 
-80°C freezers before analysis. The urine sam-
ples (500 µL) were mixed with phosphate buffer 
(250 µL, 0.25 M, pH 7.0) containing 5 mmol/L 
sodium-3-(trimethylsilyl)-2,2,3,3-tetradeuteri-
opropionate (TSP) (Cambridge Isotope Labora-
tories, Andover, MA) as an internal standard. 
Resulting solutions were centrifuged to remove 
particulate matter. The supernatant was then 
transferred into 5-mm NMR tubes for 1H NMR 
analysis. For 2D-NMR analysis, 600 µL of the 
supernatant was freeze-dried and dissolved in 
600 µL D2O before 2D-NMR analysis.
 
NMR measurements 
and the identification of signals
The 1H NMR analyses (cereal extracts and 
human urine) were performed on a Bruker 
spectrometer operating at 600 MHz (Karlsruhe, 
Germany). 1H NMR spectra were obtained us-
ing zgesgp pulse sequence (Bruker Spectro-
spin Ltd.) at 25°C with 128 scans and 65,536 
data points over a spectral width of 17942.58 
Hz. Acquisition time was 1.82 s and relaxation 
delay was 4.0 s. The NMR signals which were 
found discriminating between different anatom-
ical compartments were identified primarily us-
ing the NMR Suite 7.1 library (ChenomX Inc, 
Edmonton, Canada), Human Metabolome Data 
Base and Biological Magnetic Resonance Data 
Bank. In the event of multiplicity, the identi-
ty was confirmed with 2D NMR. In human ex-
periment, the identity of phytochemical in the 
urine originating from the cereals in the diet 
was also confirmed using 2D-NMR.  Phase-
sensitive TOCSY and COSY with presaturation 
(2k × 512 experiments) were performed with 32 
scans and a spectral width of 7195 Hz for both 
F1 and F2. The mixing time for TOCSY was 80 
ms. HSQC was performed using 32 scans and 
a spectral width of 7211 Hz and 250002 Hz for 
proton and carbon, respectively. All cereal ex-
tracts and urine samples were reconstituted in 
D2O before 2D NMR analysis.
The 1H NMR spectra data (cereal extracts) 
were processed using Bruker Topspin 1.3 soft-
ware and were Fourier-transformed after multi-
plication by a line broadening of 0.3 Hz and ref-
erenced to TSP at 0.0 ppm. Spectral phase and 
baseline were corrected manually. Each spec-
trum was integrated using Amix 3.7.3 (Bruker 
BioSpin GmbH, Rheinstetten) into 0.01 ppm in-
tegral regions (buckets) between 0.5-10 ppm, in 
which area between 4.60-5.18 ppm containing 
residual water was removed. Each spectral re-
gion was then normalized to the intensity of in-
ternal standard (TSP). 
Statistical analysis
Principal component analysis (PCA) and or-
thogonal partial least squares-discriminant 
analysis (OPLS-DA) were performed using SIM-
CA-P+ 12.0.1 software (UMETRICS, Umeå, Swe-
den) after centering and pareto-scaling of the 
data as previously described (MOAZZAMI et al. 
2011). The presence of outliers was investigat-
ed using PCA-Hotelling T2 Ellipse (95% CI) and 
the normality of multivariate data was investi-
gated using the normal probability plot of the 
PCA model. Variable influences on projection 
(VIP) values of the OPLS-DA model were used 
to determine the most important discrimina-
tive NMR bucket (signals). NMR buckets (sig-
nals) with VIP > 1 for which the corresponding 
jack-knife-based confidence intervals were not 
close to or including zero were considered dis-
criminative. The significance of OPLS-DA mod-
el was tested using cross-validated ANOVA (CV-
ANOVA), which assesses the reliability of OPLS 
models (CV-ANOVA p<0.05 means the OPLS-
DA model is reliable) (ERIKSSON et al. 2008). 
The absolute concentrations of metabolites 
with corresponding NMR signals that were found 
to be discriminative in OPLS-DA were calculat-
ed from the NMR spectra using the NMR Suite 
7.1 profiler (ChenomX Inc, Edmonton, Canada) 
and internal standard after correction for over-
lapping signals. The absolute concentrations of 
the discriminative metabolites were further in-
vestigated using ANOVA in the case of normal 
distribution, and the Mann-Whitney test when 




PCA model was fitted using NMR spectral 
data (buckets) obtained for the bran and en-
dosperm extracts. Three outliers were identi-
fied and excluded from the data set based on 
PCA-Hotelling T2 Ellipse (95% CI). The first 
and the second component explained 67.4% 
and 18.1% of spectral variation (R2X) respec-
tively (figure not shown). An OPLS-DA mod-
el was fitted including three predictive and 
six orthogonal components. The first, second, 
and third predictive components explained 
61%, 15.2%, and 1.0% of spectral variation 
respectively (model parameter: R2Y=0.937; 
Q2Y=0.876; Cross-validated ANOVA p-value 
= 2.98 × 10-38) (Fig. 1).
The first component in each model basically 
separated the bran samples obtained from rye 
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Fig. 1 - OPLS-DA separated different 
anatomical compartments of cereal 
grains based on their profile of 
metabolites measured using NMR. 
The model parameters were as follow: 
R2Y=0.937; Q2Y=0.876. Cross-
validated ANOVA p-value = 2.98 × 10-
38. Score t[1] (component 1) and score 
t[2] (component 2) are new variables 
summarizing the X-variables (the 
intensity of NMR signals corresponding 
to metabolites).
Table 1 - Discriminative metabolites along the first predictive component of the OPLS-DA model (n = 64)1,2.
Metabolite NMR signal (ppm)3 VIP (Confidence interval)4
Azelaic acid & sebacic acid5 1.304 ; 1.530 ; 2.179 2.6 (0.67) ; 1.6 (0.41) ; 1.6 (0.40)
Acetate 1.928 1.3 (0.26)
Alanine 1.494  1.1 (0.08) 
Betaine 3.269  6.9 (0.59) 
Choline 3.206; 4.085 4.4 (0.46); 2.3 (0.24)
Citrate 2.545 1.4 (0.13)
Isoleucine 0.942  1.0 (0.18)
Leucine 0.964  1.4 (0.24) 
Malate 2.663 1.1 (0.31)
Maltose  3.280; 3.727; 3.997 1.4 (0.24); 4.4 (0.49)
Succinate 2.412 1.3 (0.16)
Unknown signals6 3.778; 4.054; 4.155; 4.020 2.3 (1.07); 2.3 (0.18); 2.2 (0.23);
  4.6 (0.32)
1OPLS-DA Score scatter plot: the first component separated the bran samples (right) from the endosperm samples (left). All metabolites present in higher con-
centrations in bran. The model parameters for three predictive component fitted were as follow: R2Y=0.937; Q2Y=0.876. Cross-validated ANOVA p-value = 2.98 
× 10-38; 2Wheat endosperm (n = 18), wheat bran (n = 24), rye endosperm (n = 8), and rye bran (n = 14); 3One NMR signal from the corresponding spectral 
bucket with the highest VIP values was reported when several buckets covered a distinct NMR signal; 4NMR signals with VIP > 1 for which the corresponding 
jack-knife-based confidence intervals were not close to or including zero were considered discriminative; 5Concentration equivalent of azelaic acid; 6Unknow 
signals are located in sugar region.
and wheat from the endosperm samples (Fig. 
1, Table 1). The second component separated 
rye samples (both endosperm and bran sam-
ples) from wheat samples (Fig. 1; Table 2). Bran 
samples contained a higher content of 12 me-
tabolites and four unknown signals than en-
dosperm samples (Table 1), and their contents 
contributed to composing the first predictive 
component of the OPLS-DA model. The content 
of eight metabolites and five unknown signals 
changed along the second predictive compo-
nent of the OPLS-DA model (Table 2) separat-
ing wheat samples i.e. both anatomical com-
partments from rye samples. The concentra-
tions of all eight metabolites were found higher 
in wheat compared with rye. The metabolic sig-
nature of wheat and rye samples acquired from 
the local market did not deviate from those ac-
quired from HEALTHGRAIN project as all sample 
tightly accumulated in their corresponding spe-
cies-compartment cluster (Fig. 1). The absolute 
concentrations of metabolites that were found 
to differ between different anatomical compart-
ments and species were calculated from NMR 
spectra and further investigated using ANOVA 
or the Mann-Whitney test. A total of 12 metabo-
lites were found to differ between different spe-
cies and different anatomical compartments in 
the same species, e.g. bran compared vs en-
dosperm (Table 3; Fig. 2).
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Table 2 - Discriminative metabolites along the second predictive component of the OPLS-DA model (n = 64)1,2.
Metabolite Loading3 NMR signal (ppm)4 VIP (Confidence interval)5
Azelaic acid & sebacate6 - 1.304; 1.545; 2.179 3.3 (0.34); 2.1 (0.25); 1.9 (0.20)
Betaine - 3.269; 3.904 5.2 (0.84); 3.1 (0.39)
Choline - 3.206; 4.085 3.5 (0.42); 1.9 (0.15)
Citrate - 2.545 1.0 (0.18)
Leucine - 0.964  1.1 (0.16) 
Maltose - 3.278; 3.727; 5.257 6.1 (0.92); 3.2 (0.49); 1.0 (0.78)
Succinate - 2.414 1.1 (0.23)
Unknown signals7 + 3.778; 4.054; 4.155; 3.915; 4.043 3.7 (0.75); 1.7 (0.25); 1.6 (0.21); 2.4 (0.46); 2.7 (0.32)
1OPLS-DA Score scatter plot: the second component separated the wheat samples (below) from the rye samples (above). The model parameters for three pre-
dictive component fitted were as follow: R2Y=0.937; Q2Y=0.876. Cross-validated ANOVA p-value = 2.98 × 10-38; 2Wheat endosperm (n = 18), wheat bran (n = 
24), rye endosperm (n = 8), and rye bran (n = 14); 3Loadings: (+): higher concentration in rye samples. (-): higher concentration in wheat samples; 4One NMR 
signal from the corresponding spectral bucket with the highest VIP values was reported when several buckets covered a distinct NMR signal; 5NMR signals with 
VIP > 1 for which the corresponding jack-knife-based confidence intervals were not close to or including zero were considered discriminative; 6Concentration 
equivalent of azelaic acid; 7Unknow signals are located in sugar region.
Table 3 - Absolute concentrations of metabolites (µmol/g) found to be discriminative along the first and second predictive 
components1.
 Concentration µmol/g (mean ± SD)
Metabolite 1 : Rye endosperm 2 : Rye bran 3 : Wheat endosperm 4 : Wheat bran
Azelaic acid & sebacic acid 0.68 ± 0.21a 1.70 ± 0.27a 0.70 ± 0.16a 4.32 ± 1.25b
Acetate 1.19 ± 0.26a 3.98 ± 4.08b 0.73 ± 0.32c 2.70 ± 0.91d
Alanine  0.40 ± 0.07a 1.81 ± 0.62b 0.38 ± 0.13a 1.25 ± 0.47
Betaine 10.52 ± 2.80a 28.23 ± 6.77b 3.70 ± 2.13c 34.53 ± 9.79d
Choline 0.78 ± 0.13a 6.70 ± 1.09b 1.12 ± 0.25c 6.91 ± 1.18d
Citrate 0.55 ± 0.05a 5.25 ± 1.55b 0.62 ± 0.29c 4.93 ± 1.72b
Isoleucine 0.15 ± 0.03a 0.58  ± 0.21b 0.16 ± 0.03a 0.48 ± 0.13b
Leucine 0.37 ± 0.10a 1.52 ± 0.48b 0.35 ± 0.08a 1.40 ± 0.35b
Malate 6.04 ± 0.85a 6.22 ± 3.21b 7.43 ± 2.73a 10.24 ± 5.47a
Maltose 17.22 ± 0.182a 24.35 ± 8.46b 0.86 ± 1.52c 21.14 ± 7.27b
Succinate 0.54 ± 0.08a 1.34 ± 0.70b 0.43 ± 0.15a 1.43 ± 0.47a
1ANOVA was performed for betaine, succinate, citrate, alanine, leucine, isoleucine, and maltose. Mann-Whitney test was performed for malate, acetate, and 
choline. Metabolite means followed by different letters are significantly different (p<0.05). (Mean ± SD).
Fig. 2 - (A) A typical 1H NMR spectrum from rye bran polar extract and (B) magnified region 0.5 - 3.0 ppm. Annotated me-
tabolites: Leucine (1), isoleucine (2), Azelaic acid and sebacic acid (3), alanine (4), acetate (5), malate (6), succinate (7), cit-
rate (8), choline (9), betaine (10) and sugar region (11).
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Multivariate statistical analysis (OPLS-DA 
model) also included signals discriminating be-
tween bran and endosperm, which appeared as 
a multiplet at 1.304 ppm, a multiplet at 1.545 
ppm, and a triplet at 2.179 ppm (Fig. 2; Table 
1). Using 2D NMR and spiking with authen-
tic standard, these signals were assigned to 
two saturated, straight-chain dicarboxylic ac-
ids, namely azelaic acid (C9H16O4) and se-
bacic acid (C10H18O4). TOCSY NMR indicated 
that these signals were in the same spin sys-
tem (Fig. 3). COSY NMR also confirmed cou-
pling between (-CH2-) signals at 1.304 ppm 
and 1.545 ppm, and between (-CH2-) signals 
at 1.545 ppm and 2.179 ppm. No coupling to 
a CH3 group was observed on the TOCSY and 
COSY spectra, confirming dicarboxylic struc-
ture. The carbon chemical shifts were assigned 
from coupling to the corresponding hydrogen in 
HSQC NMR. There was a cross-peak between 
protons at 1.304 ppm and carbon at 31.484 
ppm, between protons at 1.545 ppm and carbon 
at 28.926 ppm, and between protons at 2.179 
ppm and carbon at 40.735 ppm. After applying 
new processing consisting of lining broadening 
(-1) and Gaussian broadening (0.6), the triplet 
at 2.179 appeared to be two overlapping triplets 
from azelaic acid and sebacic acid, the chemi-
cal shifts of which deviated from each other by 
1.54 Hz. The identity of azelaic acid was further 
confirmed using authentic standard. The molar 
concentration of total dicarboxylic acids (azela-
ic + sebacic acid) was then calculated and ex-
pressed as equivalent to azelaic acid (Table 3).
No signal corresponding to azelaic acid was 
detectable in the 24h urine of a male subject af-
Fig. 3 - TOCSY NMR spectrum of typical rye bran polar extract presenting coupling between a multiple at 1.304 ppm (A), a 
multiple at 1.545 ppm (B), and a triplet at 2.179 ppm (C), which belong to azelaic acid and sebacic acid, and the assignment 
of the corresponding -CH2- groups on Azelaic acid molecule.
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ter the consumption of refined wheat bread (485 
g). However, after the consumption of whole grain 
rye bread (485 g), NMR signals corresponding 
to azelaic acid with similar coupling pattern as 
azelaic acid in the bran extract were detected in 
24h urine (Fig. 4). 
The concentrations of azelaic acid and sebac-
ic acid were found to be higher in wheat and 
rye bran compared with the corresponding en-
dosperm. In addition, wheat bran had higher 
dicarboxylic acid contents than rye bran (Table 
3). To our knowledge this is the first study to re-
port comparative differences in these dicarboxyl-
ic acids in different anatomical compartments of 
wheat and rye. In humans, 60 and 17 % of the 
administered dosage of azelaic acid and sebacic 
acid, respectively, are excreted in the urine with-
in the first 12 hours (PASSI et al. 1983). It has 
been suggested that the dicarboxylic acids are to 
some extent subjected to β-oxidation, since di-
carboxylic acids found in serum and urine pos-
sess 2, 4, or 6 carbon atoms shorter than the 
corresponding administered dicarboxylic acids 
(PASSI, NAZZARO-PORRO, PICARDO, MINGRONE 
and FASELLA 1983). Recently BONDIA-PONS et al. 
using metabolomics approach have shown that 
azelaic acid beside alkylresorcinols metabolites 
and enterolactone are the most discriminate me-
tabolites, and are found in higher concentration 
urine after the intervention with whole grain rye 
bread compared with refined wheat bread (BON-
DIA-PONS et al. 2013). The present study showed 
that the main source of azelaic acid detected in 
the urine is bran, and that azelaic acid is found 
in both wheat and rye.
The relatively high abundance, anatomical 
specificity and localization in bran, pattern of 
metabolism, and previous findings regarding 
the identification of azelaic acids as discrimina-
tive metabolite in the urine after whole grain vs 
refined grain consumption  (BONDIA-PONS et al. 
2013) suggest that these dicarboxylic acids can 
be further investigated as biomarkers of expo-
sure to WG products. Further studies are need-
ed to investigate the correlation between azelaic 
acid concentration and alkylresorcinols concen-
tration, which are validated biomarkers of WG 
intake (Ross 2012) in different biofluids after the 
intake of whole grain products.  Little is known 
about the possible metabolic effects of the di-
carboxylic acids in mammals. However, azelaic 
acid is known for its antibacterial (YU and VAN 
Fig. 4 - TOCSY NMR spectrum of 24 hour urine of a 35 year old man after the consumption of 485 g whole grain rye bread. 
The pattern of coupling between signals at 1.304 ppm (A), at 1.545 ppm (B), and at 2.179 ppm (C) was similar to that ob-
served in rye bran polar extract.
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SCOTT 2004) and anticancer activities (MANOS-
ROI et al. 2007), which might contribute to the 
benefits attributed to WG intake.
Three amino acids i.e. alanine, isoleucine, and 
leucine, were also present in higher concentra-
tions in bran than in endosperm. These amino 
acids gave rise to sharp and distinct NMR sig-
nals, distinguishing them from the amino acids 
in proteins, which possess broad NMR signals. 
In addition, higher contents of succinate, citrate, 
and malate were observed in bran than in en-
dosperm. These metabolites are associated with 
the citric acid cycle and central carbon metabo-
lism. The higher levels of amino acids and citric 
acid may indicate higher metabolic activities in 
bran compared with endosperm. 
Consistent with previous studies, we observed 
higher levels of betaine and choline in bran than 
in endosperm (BRUCE et al. 2010). In addition, 
wheat bran had higher levels of betaine than rye 
bran. Circulating betaine is reported to be in-
creased postprandially in animal models (BER-
TRAM et al. 2009; YDE et al. 2012) and in fast-
ing plasma of humans after a 6-8 week inter-
vention with WG rye products (MOAZZAMI et al. 
2011; MOAZZAMI et al. 2012). Betaine acts as a 
methyl donor in the betaine-homocysteine me-
thyl transferase reaction (BHMT-R), which con-
verts homocysteine and betaine to methionine 
and N,N-dimethylglycine (DELGADO-REYES and 
GARROW 2005). Recently, in two separate hu-
man studies, we observed an increase in BH-
MT-R, as indicated by higher N,N-dimethylgly-
cine levels (MOAZZAMI et al. 2011; MOAZZAMI et 
al. 2012) and lower homocysteine levels (MOAZ-
ZAMI et al. 2011), after a 6-8 week intervention 
with WG rye products compared with refined 
wheat products, which highlights the metabolic 
effects of betaine located in the bran of cereals.
In the present study, we used NMR-based 
metabolomics as an untargeted approach to 
gain further insights into the metabolic profile 
of different anatomical compartments of cereal 
grains. NMR profiling covers metabolites with 
µmol/g concentration. NMR also proved useful 
for identification and structural determination 
of unknown metabolites associated with differ-
ent anatomical compartments.
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